Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 259

1.

Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis.

Dellinger RW, Liu-Smith F, Meyskens FL Jr.

J Photochem Photobiol B. 2014 Sep 5;138C:317-323. doi: 10.1016/j.jphotobiol.2014.06.006. Epub 2014 Jun 20. Review.

PMID:
25022944
[PubMed - as supplied by publisher]
2.

Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Albanes D, Till C, Klein EA, Goodman PJ, Mondul AM, Weinstein SJ, Taylor PR, Parnes HL, Gaziano JM, Song X, Fleshner NE, Brown PH, Meyskens FL Jr, Thompson IM.

Cancer Prev Res (Phila). 2014 Jun 24. [Epub ahead of print]

PMID:
24961880
[PubMed - as supplied by publisher]
3.

Updates of reactive oxygen species in melanoma etiology and progression.

Liu-Smith F, Dellinger R, Meyskens FL Jr.

Arch Biochem Biophys. 2014 Apr 26. pii: S0003-9861(14)00138-6. doi: 10.1016/j.abb.2014.04.007. [Epub ahead of print]

PMID:
24780245
[PubMed - as supplied by publisher]
4.

Plasma vitamin d and prostate cancer risk: results from the selenium and vitamin e cancer prevention trial.

Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1494-504. doi: 10.1158/1055-9965.EPI-14-0115. Epub 2014 Apr 14.

PMID:
24732629
[PubMed - in process]
5.

A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL Jr.

Cancer Prev Res (Phila). 2014 May;7(5):496-504. doi: 10.1158/1940-6207.CAPR-13-0189. Epub 2014 Mar 10.

PMID:
24614012
[PubMed - in process]
6.

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA.

J Natl Cancer Inst. 2014 Mar;106(3):djt456. doi: 10.1093/jnci/djt456. Epub 2014 Feb 22.

PMID:
24563519
[PubMed - indexed for MEDLINE]
7.

Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.

Meyskens FL Jr, Simoneau AR, Gerner EW.

Recent Results Cancer Res. 2014;202:115-20. doi: 10.1007/978-3-642-45195-9_14.

PMID:
24531785
[PubMed - indexed for MEDLINE]
8.

Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.

Dellinger RW, Garcia AM, Meyskens FL Jr.

Drug Metab Pharmacokinet. 2014;29(2):112-9. Epub 2013 Aug 20.

PMID:
23965644
[PubMed - in process]
Free Article
9.

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR.

J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10.

PMID:
23843441
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL Jr.

Cancer Prev Res (Phila). 2013 May;6(5):410-8. doi: 10.1158/1940-6207.CAPR-13-0004.

PMID:
23639862
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines.

Xie L, Meyskens FL Jr.

Melanoma Res. 2013 Apr;23(2):102-13. doi: 10.1097/CMR.0b013e32835df5e4.

PMID:
23344158
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells.

Dellinger RW, Matundan HH, Ahmed AS, Duong PH, Meyskens FL Jr.

PLoS One. 2012;7(10):e47696. doi: 10.1371/journal.pone.0047696. Epub 2012 Oct 22.

PMID:
23110092
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Liu F, Bessonova L, Taylor TH, Ziogas A, Meyskens FL Jr, Anton-Culver H.

Pigment Cell Melanoma Res. 2013 Jan;26(1):128-35. doi: 10.1111/pcmr.12035. Epub 2012 Nov 21.

PMID:
23095171
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells.

Liu F, Gomez Garcia AM, Meyskens FL Jr.

J Invest Dermatol. 2012 Aug;132(8):2033-41. doi: 10.1038/jid.2012.119. Epub 2012 Apr 19.

PMID:
22513785
[PubMed - indexed for MEDLINE]
Free Article
15.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437.

PMID:
21990298
[PubMed - indexed for MEDLINE]
16.

Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.

Chu DZ, Hussey MA, Alberts DS, Meyskens FL Jr, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Blanke CD, Goodman GE.

Clin Colorectal Cancer. 2011 Dec;10(4):310-6. doi: 10.1016/j.clcc.2011.06.005. Epub 2011 Jul 22.

PMID:
21782524
[PubMed - indexed for MEDLINE]
17.

Therapeutic prevention of colorectal carcinogenesis.

Meyskens FL Jr.

J Carcinog. 2011;10:13. doi: 10.4103/1477-3163.79682. Epub 2011 Apr 16. No abstract available.

PMID:
21712960
[PubMed]
Free PMC Article
18.

Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach.

Meyskens FL Jr, Gerner EW.

Cancer Prev Res (Phila). 2011 May;4(5):628-32. doi: 10.1158/1940-6207.CAPR-11-0162.

PMID:
21543341
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE.

Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Erratum in: Cancer Prev Res (Phila). 2012 Dec;5(12):1407. Dosage error in article text.

PMID:
21372035
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic.

Meyskens FL Jr, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E; C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee.

Cancer Prev Res (Phila). 2011 Mar;4(3):311-23. doi: 10.1158/1940-6207.CAPR-09-0014.

PMID:
21372031
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk